ZEBRA TECHNOLOGIES CORP-CL A (ZBRA) Stock Fundamental Analysis

NASDAQ:ZBRA • US9892071054

255.41 USD
+3.67 (+1.46%)
At close: Feb 20, 2026
255.61 USD
+0.2 (+0.08%)
Pre-Market: 2/23/2026, 8:00:00 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

5

Overall ZBRA gets a fundamental rating of 5 out of 10. We evaluated ZBRA against 124 industry peers in the Electronic Equipment, Instruments & Components industry. While ZBRA has a great profitability rating, there are some minor concerns on its financial health. ZBRA is valued quite cheap, while showing a decent growth score. This is a good combination!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • In the past year ZBRA was profitable.
  • ZBRA had a positive operating cash flow in the past year.
  • In the past 5 years ZBRA has always been profitable.
  • ZBRA had a positive operating cash flow in 4 of the past 5 years.
ZBRA Yearly Net Income VS EBIT VS OCF VS FCFZBRA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 4.93%, ZBRA is in the better half of the industry, outperforming 70.97% of the companies in the same industry.
  • With a decent Return On Equity value of 11.68%, ZBRA is doing good in the industry, outperforming 77.42% of the companies in the same industry.
  • ZBRA has a Return On Invested Capital of 9.50%. This is amongst the best in the industry. ZBRA outperforms 83.87% of its industry peers.
  • ZBRA had an Average Return On Invested Capital over the past 3 years of 9.08%. This is in line with the industry average of 8.80%.
  • The 3 year average ROIC (9.08%) for ZBRA is below the current ROIC(9.50%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.93%
ROE 11.68%
ROIC 9.5%
ROA(3y)5.2%
ROA(5y)7.04%
ROE(3y)12.05%
ROE(5y)16.23%
ROIC(3y)9.08%
ROIC(5y)11.91%
ZBRA Yearly ROA, ROE, ROICZBRA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 30

1.3 Margins

  • Looking at the Profit Margin, with a value of 7.77%, ZBRA is in the better half of the industry, outperforming 77.42% of the companies in the same industry.
  • ZBRA's Profit Margin has declined in the last couple of years.
  • Looking at the Operating Margin, with a value of 14.83%, ZBRA belongs to the top of the industry, outperforming 87.90% of the companies in the same industry.
  • ZBRA's Operating Margin has been stable in the last couple of years.
  • With an excellent Gross Margin value of 48.05%, ZBRA belongs to the best of the industry, outperforming 83.06% of the companies in the same industry.
  • In the last couple of years the Gross Margin of ZBRA has remained more or less at the same level.
Industry RankSector Rank
OM 14.83%
PM (TTM) 7.77%
GM 48.05%
OM growth 3Y-2.89%
OM growth 5Y-0.76%
PM growth 3Y-1.03%
PM growth 5Y-7.28%
GM growth 3Y1.92%
GM growth 5Y1.31%
ZBRA Yearly Profit, Operating, Gross MarginsZBRA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ZBRA is creating some value.
  • Compared to 1 year ago, ZBRA has less shares outstanding
  • Compared to 5 years ago, ZBRA has less shares outstanding
  • The debt/assets ratio for ZBRA is higher compared to a year ago.
ZBRA Yearly Shares OutstandingZBRA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
ZBRA Yearly Total Debt VS Total AssetsZBRA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

  • An Altman-Z score of 3.39 indicates that ZBRA is not in any danger for bankruptcy at the moment.
  • With a Altman-Z score value of 3.39, ZBRA perfoms like the industry average, outperforming 58.06% of the companies in the same industry.
  • ZBRA has a debt to FCF ratio of 3.01. This is a good value and a sign of high solvency as ZBRA would need 3.01 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 3.01, ZBRA is in the better half of the industry, outperforming 74.19% of the companies in the same industry.
  • ZBRA has a Debt/Equity ratio of 0.66. This is a neutral value indicating ZBRA is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.66, ZBRA is doing worse than 80.65% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF 3.01
Altman-Z 3.39
ROIC/WACC1.05
WACC9.09%
ZBRA Yearly LT Debt VS Equity VS FCFZBRA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

2.3 Liquidity

  • ZBRA has a Current Ratio of 0.97. This is a bad value and indicates that ZBRA is not financially healthy enough and could expect problems in meeting its short term obligations.
  • ZBRA has a worse Current ratio (0.97) than 91.13% of its industry peers.
  • ZBRA has a Quick Ratio of 0.97. This is a bad value and indicates that ZBRA is not financially healthy enough and could expect problems in meeting its short term obligations.
  • ZBRA has a worse Quick ratio (0.58) than 91.94% of its industry peers.
Industry RankSector Rank
Current Ratio 0.97
Quick Ratio 0.58
ZBRA Yearly Current Assets VS Current LiabilitesZBRA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • ZBRA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 17.25%, which is quite good.
  • Measured over the past 5 years, ZBRA shows a small growth in Earnings Per Share. The EPS has been growing by 4.34% on average per year.
  • The Revenue has grown by 8.33% in the past year. This is quite good.
  • The Revenue has been growing slightly by 3.94% on average over the past years.
EPS 1Y (TTM)17.25%
EPS 3Y-3.25%
EPS 5Y4.34%
EPS Q2Q%8.25%
Revenue 1Y (TTM)8.33%
Revenue growth 3Y-2.27%
Revenue growth 5Y3.94%
Sales Q2Q%9.22%

3.2 Future

  • Based on estimates for the next years, ZBRA will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.27% on average per year.
  • The Revenue is expected to grow by 11.65% on average over the next years. This is quite good.
EPS Next Y12.75%
EPS Next 2Y11.66%
EPS Next 3Y14.19%
EPS Next 5Y17.27%
Revenue Next Year10.83%
Revenue Next 2Y8.17%
Revenue Next 3Y7.33%
Revenue Next 5Y11.65%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ZBRA Yearly Revenue VS EstimatesZBRA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B
ZBRA Yearly EPS VS EstimatesZBRA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10 20 30

More info and screens

Find the best growth stocksShow best growing peers

7

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 16.12, which indicates a correct valuation of ZBRA.
  • 86.29% of the companies in the same industry are more expensive than ZBRA, based on the Price/Earnings ratio.
  • When comparing the Price/Earnings ratio of ZBRA to the average of the S&P500 Index (26.99), we can say ZBRA is valued slightly cheaper.
  • ZBRA is valuated correctly with a Price/Forward Earnings ratio of 14.30.
  • ZBRA's Price/Forward Earnings ratio is rather cheap when compared to the industry. ZBRA is cheaper than 85.48% of the companies in the same industry.
  • ZBRA is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 28.02, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 16.12
Fwd PE 14.3
ZBRA Price Earnings VS Forward Price EarningsZBRA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

  • ZBRA's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. ZBRA is cheaper than 75.00% of the companies in the same industry.
  • ZBRA's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ZBRA is cheaper than 88.71% of the companies in the same industry.
Industry RankSector Rank
P/FCF 15.57
EV/EBITDA 15.55
ZBRA Per share dataZBRA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • ZBRA has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as ZBRA's earnings are expected to grow with 14.19% in the coming years.
PEG (NY)1.26
PEG (5Y)3.72
EPS Next 2Y11.66%
EPS Next 3Y14.19%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for ZBRA!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ZEBRA TECHNOLOGIES CORP-CL A

NASDAQ:ZBRA (2/20/2026, 8:11:35 PM)

Premarket: 255.61 +0.2 (+0.08%)

255.41

+3.67 (+1.46%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)02-12
Earnings (Next)05-12
Inst Owners98.81%
Inst Owner Change-1.26%
Ins Owners0.7%
Ins Owner Change1.58%
Market Cap12.94B
Revenue(TTM)5.40B
Net Income(TTM)419.00M
Analysts79.23
Price Target343.38 (34.44%)
Short Float %2.95%
Short Ratio2.16
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.28%
Min EPS beat(2)-1.97%
Max EPS beat(2)1.41%
EPS beat(4)3
Avg EPS beat(4)3.72%
Min EPS beat(4)-1.97%
Max EPS beat(4)8.97%
EPS beat(8)6
Avg EPS beat(8)5.62%
EPS beat(12)8
Avg EPS beat(12)3.99%
EPS beat(16)11
Avg EPS beat(16)2.96%
Revenue beat(2)0
Avg Revenue beat(2)-1.79%
Min Revenue beat(2)-2.08%
Max Revenue beat(2)-1.49%
Revenue beat(4)0
Avg Revenue beat(4)-1.41%
Min Revenue beat(4)-2.08%
Max Revenue beat(4)-0.61%
Revenue beat(8)3
Avg Revenue beat(8)-0.47%
Revenue beat(12)4
Avg Revenue beat(12)-1.17%
Revenue beat(16)6
Avg Revenue beat(16)-1.21%
PT rev (1m)-3.28%
PT rev (3m)-6.16%
EPS NQ rev (1m)1.62%
EPS NQ rev (3m)1.7%
EPS NY rev (1m)-0.13%
EPS NY rev (3m)1.44%
Revenue NQ rev (1m)1.77%
Revenue NQ rev (3m)1.77%
Revenue NY rev (1m)1%
Revenue NY rev (3m)1.1%
Valuation
Industry RankSector Rank
PE 16.12
Fwd PE 14.3
P/S 2.4
P/FCF 15.57
P/OCF 14.11
P/B 3.61
P/tB N/A
EV/EBITDA 15.55
EPS(TTM)15.84
EY6.2%
EPS(NY)17.86
Fwd EY6.99%
FCF(TTM)16.4
FCFY6.42%
OCF(TTM)18.1
OCFY7.09%
SpS106.51
BVpS70.83
TBVpS-38.45
PEG (NY)1.26
PEG (5Y)3.72
Graham Number158.88
Profitability
Industry RankSector Rank
ROA 4.93%
ROE 11.68%
ROCE 12.03%
ROIC 9.5%
ROICexc 9.68%
ROICexgc 63.89%
OM 14.83%
PM (TTM) 7.77%
GM 48.05%
FCFM 15.4%
ROA(3y)5.2%
ROA(5y)7.04%
ROE(3y)12.05%
ROE(5y)16.23%
ROIC(3y)9.08%
ROIC(5y)11.91%
ROICexc(3y)9.75%
ROICexc(5y)12.66%
ROICexgc(3y)53.88%
ROICexgc(5y)104.36%
ROCE(3y)11.5%
ROCE(5y)15.08%
ROICexgc growth 3Y-21.35%
ROICexgc growth 5YN/A
ROICexc growth 3Y-12.63%
ROICexc growth 5Y-9.69%
OM growth 3Y-2.89%
OM growth 5Y-0.76%
PM growth 3Y-1.03%
PM growth 5Y-7.28%
GM growth 3Y1.92%
GM growth 5Y1.31%
F-Score5
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF 3.01
Debt/EBITDA 2.4
Cap/Depr 46.49%
Cap/Sales 1.59%
Interest Coverage 6.2
Cash Conversion 93.1%
Profit Quality 198.33%
Current Ratio 0.97
Quick Ratio 0.58
Altman-Z 3.39
F-Score5
WACC9.09%
ROIC/WACC1.05
Cap/Depr(3y)43.41%
Cap/Depr(5y)39.71%
Cap/Sales(3y)1.56%
Cap/Sales(5y)1.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)17.25%
EPS 3Y-3.25%
EPS 5Y4.34%
EPS Q2Q%8.25%
EPS Next Y12.75%
EPS Next 2Y11.66%
EPS Next 3Y14.19%
EPS Next 5Y17.27%
Revenue 1Y (TTM)8.33%
Revenue growth 3Y-2.27%
Revenue growth 5Y3.94%
Sales Q2Q%9.22%
Revenue Next Year10.83%
Revenue Next 2Y8.17%
Revenue Next 3Y7.33%
Revenue Next 5Y11.65%
EBIT growth 1Y4.58%
EBIT growth 3Y-5.1%
EBIT growth 5Y3.15%
EBIT Next Year24.95%
EBIT Next 3Y11.36%
EBIT Next 5Y17.42%
FCF growth 1Y-12.89%
FCF growth 3Y26.25%
FCF growth 5Y-1.47%
OCF growth 1Y-9.48%
OCF growth 3Y23.4%
OCF growth 5Y-0.95%

ZEBRA TECHNOLOGIES CORP-CL A / ZBRA FAQ

Can you provide the ChartMill fundamental rating for ZEBRA TECHNOLOGIES CORP-CL A?

ChartMill assigns a fundamental rating of 5 / 10 to ZBRA.


Can you provide the valuation status for ZEBRA TECHNOLOGIES CORP-CL A?

ChartMill assigns a valuation rating of 7 / 10 to ZEBRA TECHNOLOGIES CORP-CL A (ZBRA). This can be considered as Undervalued.


How profitable is ZEBRA TECHNOLOGIES CORP-CL A (ZBRA) stock?

ZEBRA TECHNOLOGIES CORP-CL A (ZBRA) has a profitability rating of 7 / 10.


How financially healthy is ZEBRA TECHNOLOGIES CORP-CL A?

The financial health rating of ZEBRA TECHNOLOGIES CORP-CL A (ZBRA) is 4 / 10.